QuickCool AB (publ) signs letter of intent with Biovation
As previously communicated, QuickCool AB (publ) (“QuickCool”) proposes to transform the existing QuickCool company into a holding structure to invest in cannabis and other alternative medical markets as well as to, in a separate new subsidiary, continue to develop QuickCool® SYSTEM.As part of the change of business, QuickCool intends to enter an agreement with Biovation Sciences Ltd. (“Biovation”) regarding investment advice and support for investments in additional operations. As of 19 November 2019, QuickCool and Biovation have entered into a letter of intent on such collaboration.